Imatinib Not Yet Recruiting Phase 2 Trials for Leukemia, Myelogenous, Chronic, BCR-ABL Positive Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02687425Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia